Sale!

CABP2 Gene Deafness Autosomal Recessive Type 93 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The CABP2 Gene Deafness Autosomal Recessive Type 93 Genetic Test is a specialized diagnostic assessment aimed at detecting mutations in the CABP2 gene, which are known to cause Autosomal Recessive Deafness Type 93 (DFNB93), a form of non-syndromic hearing loss. This genetic condition is inherited in an autosomal recessive pattern, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected. The test is crucial for families with a history of hearing loss, as early identification can facilitate timely intervention and support.

Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific mutations in the CABP2 gene. The outcome of this test can provide essential information for affected families, including guidance on managing the condition and understanding the risk for future children.

The cost of the CABP2 Gene Deafness Autosomal Recessive Type 93 Genetic Test at DNA Labs UAE is 4400 AED. This cost reflects the comprehensive nature of the test, from sample collection and genetic sequencing to the expert analysis and reporting of results. While the price may seem significant, the value of the insights gained for affected individuals and their families is immeasurable, offering a clearer path to coping with the condition and making informed decisions about their health and lifestyle.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CABP2 Gene Deafness Autosomal Recessive Type 93 Genetic Test

Welcome to DNA Labs UAE, a leading genetic lab offering the CABP2 Gene Deafness autosomal recessive type 93 Genetic Test. This test is designed to diagnose and identify individuals with autosomal recessive type 93 (DFNB93) deafness, which is associated with the CABP2 gene.

Test Details

The CABP2 gene is responsible for a specific type of deafness known as autosomal recessive type 93 (DFNB93). This condition is inherited in an autosomal recessive manner, meaning that both copies of the gene must be mutated for an individual to develop the condition. Our NGS (Next Generation Sequencing) genetic testing utilizes advanced sequencing technologies to analyze multiple genes simultaneously, including the CABP2 gene. By sequencing the CABP2 gene, we can identify any mutations or variations that may be present, allowing for an accurate diagnosis of DFNB93 deafness.

Components and Price

The CABP2 Gene Deafness autosomal recessive type 93 Genetic Test is priced at 4400.0 AED. The test requires a sample of either blood, extracted DNA, or one drop of blood on an FTA Card.

Report Delivery

After the sample is collected, the report will be delivered within 3 to 4 weeks. Our efficient laboratory processes ensure timely and accurate results.

Test Type and Doctor

The CABP2 Gene Deafness autosomal recessive type 93 Genetic Test falls under the category of Ear Nose Throat Disorders. It is recommended to consult with an ENT Doctor for this test.

Test Department

The CABP2 Gene Deafness autosomal recessive type 93 Genetic Test is conducted in our Genetics department. Our experienced team of geneticists ensures reliable and precise testing.

Pre Test Information

Before undergoing the SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a Genetic Counselling session is recommended to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A13. This information helps in accurate interpretation of the test results and provides valuable insights for genetic counseling and family planning.

It’s crucial to note that genetic testing should always be conducted and interpreted by a qualified healthcare professional or genetic counselor. They possess the expertise to provide accurate and personalized information about the results and their implications.

Test Name CABP2 Gene Deafness autosomal recessive type 93 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Ear Nose Throat Disorders
Doctor ENT Doctor
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with SLC52A2 Gene Brown-Vialetto-Van Laere syndrome type 2 NGS Genetic DNA Test gene SLC52A13
Test Details

The CABP2 gene is associated with a specific type of deafness known as autosomal recessive type 93 (DFNB93). This genetic condition is inherited in an autosomal recessive manner, meaning that an individual must inherit two copies of the mutated gene (one from each parent) in order to develop the condition.

NGS (Next Generation Sequencing) genetic testing is a type of genetic testing that utilizes advanced sequencing technologies to analyze multiple genes simultaneously. In the case of CABP2 gene deafness, an NGS genetic test would involve sequencing the CABP2 gene to identify any mutations or variations that may be present.

This type of genetic testing can be used to diagnose individuals with suspected DFNB93 deafness or to identify carriers of the mutated gene. It can also be helpful for genetic counseling and family planning purposes.

It’s important to note that genetic testing should be conducted and interpreted by a qualified healthcare professional or genetic counselor who can provide accurate and personalized information about the results and their implications.